Ultragenyx Pharmaceutical (RARE) Cash from Investing Activities Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 30.54% |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | -34.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.63% |
| Dec 31, 2025 | 25.05% |
| Sep 30, 2025 | 39.66% |
| Jun 30, 2025 | -3.54% |
| Mar 31, 2025 | 73.38% |
| Dec 31, 2024 | 14.07% |
| Sep 30, 2024 | -89.07% |
| Jun 30, 2024 | 51.37% |
| Mar 31, 2024 | 36.04% |
| Dec 31, 2023 | -45.70% |
| Sep 30, 2023 | 38.75% |
| Jun 30, 2023 | 46.65% |
| Mar 31, 2023 | 46.90% |
| Dec 31, 2022 | -65.72% |
| Sep 30, 2022 | -59.28% |
| Jun 30, 2022 | 49.70% |
| Mar 31, 2022 | 28.26% |
| Dec 31, 2021 | -2.08% |
| Sep 30, 2021 | -65.28% |
| Jun 30, 2021 | 7.47% |
| Mar 31, 2021 | -36.95% |
| Dec 31, 2020 | 19.49% |
| Sep 30, 2020 | -73.41% |
| Jun 30, 2020 | -59.88% |
| Mar 31, 2020 | -107.68% |
| Dec 31, 2019 | 125.09% |
| Sep 30, 2019 | 14.74% |
| Jun 30, 2019 | -64.31% |
| Mar 31, 2019 | -88.02% |
| Dec 31, 2018 | 61.24% |
| Sep 30, 2018 | 28.32% |
| Jun 30, 2018 | 22.30% |
| Mar 31, 2018 | -159.49% |
| Dec 31, 2017 | 75.13% |
| Sep 30, 2017 | 61.33% |
| Jun 30, 2017 | 8.46% |
| Mar 31, 2017 | 45.44% |
| Dec 31, 2016 | -38.27% |
| Sep 30, 2016 | 309.60% |
| Jun 30, 2016 | 36.77% |
| Mar 31, 2016 | 50.99% |